[go: up one dir, main page]

TN2013000081A1 - Adenosine a1 agonists for the treatment of glaucoma and ocular hypertension - Google Patents

Adenosine a1 agonists for the treatment of glaucoma and ocular hypertension

Info

Publication number
TN2013000081A1
TN2013000081A1 TNP2013000081A TN2013000081A TN2013000081A1 TN 2013000081 A1 TN2013000081 A1 TN 2013000081A1 TN P2013000081 A TNP2013000081 A TN P2013000081A TN 2013000081 A TN2013000081 A TN 2013000081A TN 2013000081 A1 TN2013000081 A1 TN 2013000081A1
Authority
TN
Tunisia
Prior art keywords
glaucoma
treatment
agonists
ocular hypertension
adenosine
Prior art date
Application number
TNP2013000081A
Other languages
French (fr)
Inventor
Jurgen Klar
Degenfeld Georges Von
Hans Georg Lerchen
Kupper Albrecht
Andreas Knorr
Peter Sandner
Daniel Meibom
Original Assignee
Bayer Ip Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2011/064829 external-priority patent/WO2012028585A1/en
Application filed by Bayer Ip Gmbh filed Critical Bayer Ip Gmbh
Publication of TN2013000081A1 publication Critical patent/TN2013000081A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to the use of selective adenosine A1 agonists, in particular the dicyanopyridines of formula (I), for the treatment and/or prophylaxis of glaucoma and ocular hypertension as well as the their use for the production of a medicament for the treatment and/or prophylaxis of glaucoma and ocular hypertension.
TNP2013000081A 2011-08-29 2013-02-28 Adenosine a1 agonists for the treatment of glaucoma and ocular hypertension TN2013000081A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2011/064829 WO2012028585A1 (en) 2010-09-02 2011-08-29 Adenosine a1 agonists for the treatment of glaucoma and ocular hypertension

Publications (1)

Publication Number Publication Date
TN2013000081A1 true TN2013000081A1 (en) 2014-06-25

Family

ID=54360774

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2013000081A TN2013000081A1 (en) 2011-08-29 2013-02-28 Adenosine a1 agonists for the treatment of glaucoma and ocular hypertension

Country Status (1)

Country Link
TN (1) TN2013000081A1 (en)

Similar Documents

Publication Publication Date Title
PH12014501045B1 (en) Purine derivatives for the treatment of viral infections
IN2015DN01156A (en)
MX364486B (en) Pyridazinone-amides derivatives.
PH12014502496B1 (en) Bicyclically substituted uracils and the use thereof
PH12015500274A1 (en) Alkylpyrimidine derivatives for the treatment of viral infections and further diseases
PH12013501579A1 (en) Androgen composition for treating an opthalmic condition
MY170878A (en) [1,2,3] triazolo [4,5-d] pyrimidine derivatives as agonists of the cannabinoid receptor 2
PH12015501363A1 (en) Chloro-pyrazine carboxamide derivatives with epithelial sodium channel blocking activity
MX2016004406A (en) 1,4-cyclohexylamine derivatives and processes for the preparation thereof.
PH12014501967B1 (en) Benzodioxanes in combination with other actives for inhibiting leukotriene production
CA2878796C (en) Derivatives of pyridinone as inhibitors for tissue transglutaminase
MX2013001204A (en) Compounds for the treatment/prevention of ocular inflammatory diseases.
MX362271B (en) A crystalline form of cyclosporine a, methods of preparation, and methods for use thereof.
MY160383A (en) Adenosine A1 agonists for the treatment of glaucoma and ocular hypertension
PH12014501195A1 (en) Novel 2h-indazoles as ep2, receptor antagonists
NZ704178A (en) Difluorolactam compounds as ep4 receptor-selective agonists for use in the treatment of ep4-mediated diseases and conditions
AU2012307449A8 (en) Sulfonic acid salts of heterocyclylamide-substituted imidazoles
MX2014005538A (en) 1-pyridazinyl-hydroxyimino- 3- phenyl- propanes as gpbar1 agonists.
EA019080B9 (en) Alpha-crystalline form of carbabenzpyride
TN2013000081A1 (en) Adenosine a1 agonists for the treatment of glaucoma and ocular hypertension
NZ717880A (en) Glucopyranosyl-substituted indole-urea derivatives and their use as sglt inhibitors
MX2014004853A (en) 1-cycloalkyl- or 1-heterocyclyl-hydroxyimino-3-phenyl-propanes.
UA79866U (en) use of derivatives of 2-oxoindoline-3-glyoxalic acid as agents with antidepressive action